Additionally, the combinational treatment led to the upregulation of gene encoding ICAM1/2, the cell adhesion molecules, which activate PLCγ, a component of the Ca signalling pathway, facilitating the recognition of cancer cells by NK cells. This evidence concerns the gene ICAM1 and cancer.